<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html>
<head>
	<meta http-equiv="content-type" content="text/html; charset=utf-8"/>
	<title></title>
	<meta name="generator" content="LibreOffice 5.0.2.2 (Linux)"/>
	<meta name="author" content="HenryLaptop"/>
	<meta name="created" content="2015-02-15T11:51:00"/>
	<meta name="changedby" content="HenryLaptop"/>
	<meta name="changed" content="2015-02-15T11:51:00"/>
	<meta name="AppVersion" content="14.0000"/>
	<meta name="DocSecurity" content="0"/>
	<meta name="HyperlinksChanged" content="false"/>
	<meta name="LinksUpToDate" content="false"/>
	<meta name="ScaleCrop" content="false"/>
	<meta name="ShareDoc" content="false"/>
	<style type="text/css">
		@page { size: 8.5in 11in; margin: 1in }
		p { margin-bottom: 0.1in; direction: ltr; line-height: 120%; text-align: left; orphans: 2; widows: 2 }
		a:link { color: #0000ff }
	</style>
</head>
<body lang="en-US" link="#0000ff" dir="ltr">
<p style="margin-bottom: 0.05in; line-height: 100%"><font color="#005c46"><font face="Arial, serif"><font size="6" style="font-size: 24pt"><b>Clinical
trial design</b></font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#444444"><font face="Arial, serif"><font size="3" style="font-size: 11pt"><b>If
you’re asked to take part in a phase 2 or phase 3 trial, you may
hear terms such as controlled trials, placebo, randomisation, blind
trials and double-blind trials.</b></font></font></font></p>
<p style="margin-bottom: 0.05in; line-height: 100%"><a name="DynamicJumpMenuManager_Top1"></a>
<font color="#01a245"><font face="Arial, serif"><font size="5" style="font-size: 18pt"><b>On
this page</b></font></font></font></p>
<ul>
	<li/>
<p style="margin-bottom: 0in; line-height: 100%"><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Clinicaltrials/Trialdesign.aspx#DynamicJumpMenuManager_6_Anchor_1"><font color="#6ba71c"><font face="Arial, serif"><font size="2" style="font-size: 9pt"><u>Controlled
	trials</u></font></font></font></a></p>
	<li/>
<p style="margin-bottom: 0in; line-height: 100%"><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Clinicaltrials/Trialdesign.aspx#DynamicJumpMenuManager_6_Anchor_2"><font color="#6ba71c"><font face="Arial, serif"><font size="2" style="font-size: 9pt"><u>Placebo</u></font></font></font></a></p>
	<li/>
<p style="margin-bottom: 0in; line-height: 100%"><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Clinicaltrials/Trialdesign.aspx#DynamicJumpMenuManager_6_Anchor_3"><font color="#6ba71c"><font face="Arial, serif"><font size="2" style="font-size: 9pt"><u>Randomisation</u></font></font></font></a></p>
	<li/>
<p style="margin-bottom: 0in; line-height: 100%"><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Clinicaltrials/Trialdesign.aspx#DynamicJumpMenuManager_6_Anchor_4"><font color="#6ba71c"><font face="Arial, serif"><font size="2" style="font-size: 9pt"><u>Blind
	trials and double-blind trials</u></font></font></font></a></p>
	<li/>
<p style="margin-bottom: 0.08in; line-height: 100%"><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Clinicaltrials/Trialdesign.aspx#DynamicJumpMenuManager_6_Anchor_5"><font color="#6ba71c"><font face="Arial, serif"><font size="2" style="font-size: 9pt"><u>Entry
	criteria</u></font></font></font></a></p>
</ul>
<p style="margin-top: 0.16in; margin-bottom: 0.1in; border-top: none; border-bottom: 2.25pt solid #8cc63f; border-left: none; border-right: none; padding-top: 0in; padding-bottom: 0.06in; padding-left: 0in; padding-right: 0in; line-height: 100%"><a name="DynamicJumpMenuManager_6_Anchor_1"></a>
<font color="#006f51"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><b>Controlled
trials</b></font></font></font><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Clinicaltrials/Trialdesign.aspx#DynamicJumpMenuManager_Top1"><font color="#6ba71c"><font face="Arial, serif"><font size="2" style="font-size: 9pt"><u>Back
to top</u></font></font></font></a></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">In
most trials, one group of patients will have the trial treatment and
one group will have the standard treatment. The people having the
trial treatment are called the trial group and the people having the
standard treatment are the control group. The control group is
compared against the treatment group. The results of both groups are
compared to:</font></font></font></p>
<ul>
	<li/>
<p style="margin-bottom: 0in; line-height: 100%"><font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">see
	if there’s any benefit from the new treatment</font></font></font></p>
	<li/>
<p style="margin-bottom: 0in; line-height: 100%"><font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">see
	if the side effects are better, worse or different</font></font></font></p>
	<li/>
<p style="margin-bottom: 0in; line-height: 100%"><font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">measure
	how much of the improvement in the patients is due to the new
	treatment and how much would have happened by chance or is due to
	standard treatment.</font></font></font></p>
</ul>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Sometimes,
the standard treatment is to ‘watch and wait’. This means that no
treatment is given unless the cancer starts to develop or cause
symptoms.</font></font></font></p>
<p style="margin-top: 0.16in; margin-bottom: 0.1in; border-top: none; border-bottom: 2.25pt solid #8cc63f; border-left: none; border-right: none; padding-top: 0in; padding-bottom: 0.06in; padding-left: 0in; padding-right: 0in; line-height: 100%"><a name="DynamicJumpMenuManager_6_Anchor_2"></a><a name="Placebo"></a>
<font color="#006f51"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><b>Placebo</b></font></font></font><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Clinicaltrials/Trialdesign.aspx#DynamicJumpMenuManager_Top1"><font color="#6ba71c"><font face="Arial, serif"><font size="2" style="font-size: 9pt"><u>Back
to top</u></font></font></font></a></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">In
some situations where there is no standard treatment to compare with
the trial treatment, patients may be given a placebo. A placebo is an
inactive treatment that’s designed to look exactly like a real one.
They can only be used in trials where it’s possible to make the
placebo look like the real trial treatment, for example with some
drugs.</font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Placebos
may be used when a therapy, such as a targeted therapy, is being
added to the standard treatment to see whether this gives better
results. One group of people will be given the standard treatment
plus the trial therapy, and one group of people will be given the
standard treatment plus a placebo. People who take part in a trial
that uses a placebo won’t know whether they’re getting the actual
treatment or the placebo.</font></font></font></p>
<p style="margin-top: 0.16in; margin-bottom: 0.1in; border-top: none; border-bottom: 2.25pt solid #8cc63f; border-left: none; border-right: none; padding-top: 0in; padding-bottom: 0.06in; padding-left: 0in; padding-right: 0in; line-height: 100%"><a name="DynamicJumpMenuManager_6_Anchor_3"></a><a name="Randomisation"></a>
<font color="#006f51"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><b>Randomisation</b></font></font></font><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Clinicaltrials/Trialdesign.aspx#DynamicJumpMenuManager_Top1"><font color="#6ba71c"><font face="Arial, serif"><font size="2" style="font-size: 9pt"><u>Back
to top</u></font></font></font></a></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Most
phase 3 and some phase 2 trials are randomised. In a randomised
trial, a computer places patients into treatment groups. This means
that if you agree to take part, neither you nor your doctors will be
able to choose which treatment you’re given.</font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Trials
are often randomised because if the researchers or doctors were to
decide who should get which treatment, they might be influenced by
what they know about their patients. This means they might put people
who they think are more or less likely to respond to a new treatment
into a particular group. This would introduce bias, making the
results unreliable.</font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Bias
can be prevented if people are allocated to treatment groups by a
computer. The computer can match the groups so that they are similar.
For example, they can be matched so that each group has a similar mix
of patients of different ages, gender or state of health. By using
matched groups, if one group does better than another group, it’s
likely to be because of the treatment.</font></font></font></p>
<p style="margin-top: 0.16in; margin-bottom: 0.1in; border-top: none; border-bottom: 2.25pt solid #8cc63f; border-left: none; border-right: none; padding-top: 0in; padding-bottom: 0.06in; padding-left: 0in; padding-right: 0in; line-height: 100%"><a name="DynamicJumpMenuManager_6_Anchor_4"></a>
<font color="#006f51"><font face="Arial, serif"><font size="5" style="font-size: 17pt"><b>Blind
trials and double-blind trials</b></font></font></font><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Clinicaltrials/Trialdesign.aspx#DynamicJumpMenuManager_Top1"><font color="#6ba71c"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><u>Back
to top</u></font></font></font></a></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">If
you take part in a trial of a new drug, you may not be told which
treatment group you are in. This is called a blind trial. The
medicine used will look the same whether it’s the new treatment,
standard treatment or a placebo.</font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Some
randomised trials are called double-blind trials. This means that
neither you nor the doctor treating you will know which treatment
you’re getting. Your doctor opens a specially coded treatment pack
and only the trial organisers know which drug it contains. In an
emergency, your doctor can find out from the trial coordinators which
treatment you’re having, or the pharmacy department at the hospital
will be able to break the code.</font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Blind
trials or double-blind trials aim to reduce any bias. For example,
knowing you’re having a new treatment might make you feel more
positive or more negative. This could influence what you report to
the researchers. Similarly, if your medical team knew that you were
having a new treatment for which they had high hopes, this might
affect how they judged your response to it.</font></font></font></p>
<p style="margin-top: 0.16in; margin-bottom: 0.1in; border-top: none; border-bottom: 2.25pt solid #8cc63f; border-left: none; border-right: none; padding-top: 0in; padding-bottom: 0.06in; padding-left: 0in; padding-right: 0in; line-height: 100%"><a name="DynamicJumpMenuManager_6_Anchor_5"></a>
<font color="#006f51"><font face="Arial, serif"><font size="5" style="font-size: 17pt"><b>Entry
criteria</b></font></font></font><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Clinicaltrials/Trialdesign.aspx#DynamicJumpMenuManager_Top1"><font color="#6ba71c"><font face="Arial, serif"><font size="3" style="font-size: 12pt"><u>Back
to top</u></font></font></font></a></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Clinical
trials are often carried out in very specific patient groups. This
means that it’s only possible to take part in a trial if you fit
the group criteria. For example, the cancer may need to be at a
certain stage (staging takes into account the cancer’s size,
position in the body and whether it has begun to spread). Your cancer
specialist can tell you if you’re suitable for a specific trial.</font></font></font></p>
<p style="margin-bottom: 0.14in; line-height: 115%"><br/>
<br/>

</p>
</body>
</html>